https://myoncopath.com/wp-content/uploads/2019/01/shutterstock_1221406465.jpg
3140
6000
hwetzel
https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg
hwetzel2019-01-18 18:29:102019-01-21 17:09:00CNN Article: Breast cancer testing guidelines are out of date, missing genetic screening
https://myoncopath.com/wp-content/uploads/2018/04/Genetic-Counselor-Ordering-Companion-Diagnostic-Test.jpg
4016
6016
Ben Harmssen
https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg
Ben Harmssen2018-04-03 02:44:382019-02-01 20:44:26FoundationOne CDx Comprehensive Genomic Profiling for Solid Tumors Now Commercially Available
https://myoncopath.com/wp-content/uploads/2018/01/Breast-Cancer-Stats-for-BRCA-Genetic-Mutation-Mammograms.jpg
1290
1942
Ben Harmssen
https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg
Ben Harmssen2018-01-12 21:14:002019-02-01 20:46:10FDA approves first treatment for breast cancer with a certain inherited genetic mutation
https://myoncopath.com/wp-content/uploads/2017/12/Targeted-Therapy-Genetic-Testing-in-Lab.jpg
3744
5616
Ben Harmssen
https://myoncopath.com/wp-content/uploads/2017/07/myoncopath_test_3.svg
Ben Harmssen2017-12-13 19:20:092019-02-01 20:56:07FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers